Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Frumovitz

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Gynecologic Oncology|January 12, 2020
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)Alessandro D Santin, Wei Deng, Michael Frumovitz, et al.
Gynecologic Oncology|December 3, 2014
Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancerNicole D Fleming, Michael Frumovitz, Kathleen M Schmeler, et al.
Gynecologic Oncology|May 23, 2017
A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancerPamela T Soliman, Shannon N Westin, Shayan Dioun, et al.
Gynecologic Oncology|January 3, 2012
Proceedings from the 9th International Conference on Ovarian CancerKathleen M Schmeler, Anil K Sood, Katherine M Bell-McGuinn, et al.
Gynecologic Oncology|June 20, 2014
Minimally invasive surgery for endometrial cancer: does operative start time impact surgical and oncologic outcomes?Katrina N Slaughter, Michael Frumovitz, Kathleen M Schmeler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Quality of life and sexual functioning in cervical cancer survivorsMichael Frumovitz, Charlotte C Sun, Leslie R Schover, et al.
Cancer|June 22, 2019
Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective studyKatherine I Stewart, Beth Chasen, William Erwin, et al.
Gynecologic Oncology|October 13, 2022
Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progressionDevarati Mitra, Morgan Farr, Priyadharsini Nagarajan, et al.
Gynecologic Oncology|June 7, 2012
Risk factors for prolonged hospitalization after gynecologic laparoscopic surgeryBehrouz Zand, Michael Frumovitz, Matias F Jofre, et al.
Gynecologic Oncology|January 14, 2012
Impact of surgeon volume on patient safety in laparoscopic gynecologic surgeryMichael J Worley, Carlos Anwandter, Charlotte C Sun, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Gynecologic Oncology|January 12, 2020
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)Alessandro D Santin, Wei Deng, Michael Frumovitz, et al.
Gynecologic Oncology|December 3, 2014
Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancerNicole D Fleming, Michael Frumovitz, Kathleen M Schmeler, et al.
Gynecologic Oncology|May 23, 2017
A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancerPamela T Soliman, Shannon N Westin, Shayan Dioun, et al.
Gynecologic Oncology|January 3, 2012
Proceedings from the 9th International Conference on Ovarian CancerKathleen M Schmeler, Anil K Sood, Katherine M Bell-McGuinn, et al.
Gynecologic Oncology|June 20, 2014
Minimally invasive surgery for endometrial cancer: does operative start time impact surgical and oncologic outcomes?Katrina N Slaughter, Michael Frumovitz, Kathleen M Schmeler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Quality of life and sexual functioning in cervical cancer survivorsMichael Frumovitz, Charlotte C Sun, Leslie R Schover, et al.
Cancer|June 22, 2019
Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective studyKatherine I Stewart, Beth Chasen, William Erwin, et al.
Gynecologic Oncology|October 13, 2022
Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progressionDevarati Mitra, Morgan Farr, Priyadharsini Nagarajan, et al.
Gynecologic Oncology|June 7, 2012
Risk factors for prolonged hospitalization after gynecologic laparoscopic surgeryBehrouz Zand, Michael Frumovitz, Matias F Jofre, et al.
Gynecologic Oncology|January 14, 2012
Impact of surgeon volume on patient safety in laparoscopic gynecologic surgeryMichael J Worley, Carlos Anwandter, Charlotte C Sun, et al.
Pageof 23